Blog
Join our newsletter
Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CMO, Dr. Annie De Groot.
The Season of Gratitude
Talking out loud to myself (and about 7000...
Setting the Standards for Generics
October is Rocking! Off to Amsterdam and...
Falling Forward: New Leadership, New Tools, New Events
September Falling Forward The Transition...
Immunogenicity Risk Assessment: In Silico, In Vitro, and What’s Next
Immunogenicity Risk Assessment: In Silico, In...
The Time is Now for Tregs!
The Time is Now for Tregs! I spoke at a...
Immunogenicity is Personal
Immunogenicity is Personal The Birds are Coming...
Tregitopes by Another Name?
Tregitopes by Another Name? OK, sometimes, I am...
ISPRI for Bi-Specifics? Yes, we Can!
ISPRI for Bi-Specifics? Yes, we Can! ...
Where will we meet you in 2024?
Where will we meet you in 2024?...
FDA Request for “Integrated Summary of Immunogenicity”
FDA Request for "Integrated Summary of...
How AI + HI Are Transforming Vaccine Development (and Why We’re Grateful for You)
This is a two-way street Hey Hey, Hallo, Hola,...
Fearless Truth in Biotechnology
Amsterdam Immunogenicity and Tolerance Seminar:...